A. Benavente

New basic membrane-destabilizing peptides for plasmid-based gene delivery in vitro and in vivo.

R. Brasseur, G. Divita, F. Heitz, 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

Synthesis in E. coli of α1-antitrypsin variants of therapeutic potential for emphysema and thrombosis

R. Crystal, A. Benavente, J. Lecocq, 1985, Nature.

Antiprotease targeting: altered specificity of alpha 1-antitrypsin by amino acid replacement at the reactive centre.

R. Crystal, A. Benavente, M. Courtney, 1986, Revue francaise de transfusion et immuno-hematologie.

The influence of mRNA primary and secondary structure on human IFN-γ gene expression in E. coli

T. Faure, A. Benavente, J. Lecocq, 1984 .

Up to 100-Fold Increase of Apparent Gene Expression in the Presence of Epstein-Barr Virus oriP Sequences and EBNA1: Implications of the Nuclear Import of Plasmids

V. Patzel, G. Sczakiel, K. Rittner, 1998, Journal of Virology.

Ligation of exogenous linear DNA after gene transfer in vitro and in vivo

K. Rittner, A. Benavente, E. Jacobs, 2003, The journal of gene medicine.

High-level production of biologically active human alpha 1-antitrypsin in Escherichia coli.

R. Lathe, M. Jaye, A. Balland, 1984, Proceedings of the National Academy of Sciences of the United States of America.